Published
Oxford University researchers have found that their COVID-19 vaccine is highly effective in interim results from Phase III human trials.
Our preliminary data indicates that the vaccine is 70.4% effective. Excitingly, tests on two different dose regimes show that that our vaccine could be 90% effective if administered at a half dose and then at a full dose. It was shown to be 62% effective if administered in two full doses.
Our partners will now begin submitting for regulatory approval, meaning we’re one step closer to supplying it at low cost around the world, using existing vaccine distribution methods.
For more on this story: https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine
Our preliminary data indicates that the vaccine is 70.4% effective. Excitingly, tests on two different dose regimes show that that our vaccine could be 90% effective if administered at a half dose and then at a full dose. It was shown to be 62% effective if administered in two full doses.
Our partners will now begin submitting for regulatory approval, meaning we’re one step closer to supplying it at low cost around the world, using existing vaccine distribution methods.
For more on this story: https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine
- Category
- Academic
- Tags
- University of Oxford, Oxford, University
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
03:00
Is the Flu Vaccine Less Effective If You Are Obese?
-
05:51
Tesco Interim Results 2016/17 - Update from Dave Lewis and Alan Stewart
-
00:41
Oxford launches its first results from the COVID-19 vaccine trial
-
02:36
Human challenge trial to study immune response to COVID-19
-
00:55
The Black Death today: Oxford launches clinical trial of a plague vaccine
-
00:48
Oxford University's 'vaccine for the world' is effective
-
35:49
The 5:30 A.M. Warrior Call: The FDA Approves Phase 2 Testing of Coronavirus Vaccine (5/8/2020)
-
02:30
Oxford's scientists explain the Phase I/II results for the COVID-19 vaccine
-
09:33
The 10 Habits of Highly Effective Language Learners
-
11:05
Covid-19: Drug trial gives hope: BBC News Review
-
25:50
COVID Conversations: Oxford's COVID-19 Government Response Tracker
-
06:18
COVID-19 coronavirus vaccine: everything you need to know
-
13:48
10 Habits of Highly Effective Learners | English November Review
-
01:00
The world's biggest randomised clinical trial of COVID-19 treatments is a year old
-
09:17
10 Habits of Highly Effective Learners | German November Review
-
04:01
What's a human challenge trial of COVID-19 like?
-
09:33
The 10 Habits of Highly Effective Language Learners
-
00:54
Human trial of new COVID-19 vaccine begins
-
03:54
Why You Should Still Get The Vaccine If You've Already Had Covid | Dr. Ian Smith
-
07:51
Tesco Interim Results 2014/15: Interview with CEO Dave Lewis
-
01:36
Cancer Vaccine Trial Starting on Patients
-
34:09
The 5:30 A.M. Warrior Call: COVID-19 Vaccine to Begin Human Trial (4/07/2020)
